The Science of Longevity, Life Expectancy and Healthy Life …€¦ · The Science of Longevity,...

Post on 25-May-2020

5 views 0 download

Transcript of The Science of Longevity, Life Expectancy and Healthy Life …€¦ · The Science of Longevity,...

Professor Sarah Harper CBE Clore Professor of Gerontology

University of Oxford

October 22, 2019

The Science of Longevity, Life

Expectancy and Healthy Life

Expectancy

Worlds 1st Super- centenarian

Geert Adriaans Boomgaard

Worlds 1st Super- centenarian

FOUGHT WITH NAPOLEON….

Geert Adriaans Boomgaard

21 September 1788 Groningen, Netherlands

3 February 1899

110 years 135 days

Record male life until 1966

Jeanne Calment of France, who died in 1997 aged 122 years, 164 days, had the longest human lifespan documented

The oldest verified man is Jiroemon Kimura of Japan, who died in 2013 aged 116 years and 54 days

Multi-disciplinary Questions

We now understand for example

• that cellular processes are affected by behaviour and

environment, and that external factors may influence health

and ageing even at the level of genetic structures

• that society frames these processes and even global political

and economic structures have an influence

Resilience-enhancing factors such as exercise, social networks and economic security, which can protect against damage

Cell to Society: both biological and social factors are implicated in damage and repair, and interact closely

Stressorssuch as retirement, bereavement or disease, which manifest themselves during major life-course events and transitions

• To grow old in a society or world that is in itself ageing is different

from growing old in a predominantly young population. In

particular, resources start to shift as both politically and

economically older adults start to dominate societies’ agendas.

• For example, biological and cellular research into ageing has

increased considerably over past decades. Associated with

increases in life expectancies these trends, older populations have

attracted political, policy, scientific and societal interest leading to

greater funding and promotion of age-related research in all

fields.

1. Will increases in life expectancy continue?

How long will our children and

grandchildren live for?

2. Will advances in life expectancy be matched by advances in healthy life expectancy?

• Will increases in both life expectancy and in life extension or longevity continue?

– will there be an increase in average years lived by humans and also maximum years attained by a human being?

Life expectancy, selected OECD countries, men and women, birth

Source: OECD

72

74

76

78

80

82

84

86

88

2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015

Re

mai

nin

g ye

ars

of

life

Birth

Spain women

Japan women

FrancewomenUK women

USA women

Spain men

Japan men

Life expectancy, selected OECD countries, men and women, age 60

Source: WHO

15

16

17

18

19

20

21

22

23

24

25

2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015

Re

mai

nin

g ye

ars

of

life

Spain women

Japan women

FrancewomenUK women

USA women

Spain men

Japan men

France men

UK men

Life expectancy, selected OECD countries, men and women, age 80

Source: OECD

6

7

8

9

10

11

12

2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015

Re

mai

nin

g ye

ars

of

life

Age 80

Spain women

Japan women

France women

UK women

USA women

Spain men

Japan men

France men

UK men

USA men

Women live longer than Men

Female life expectancy at birth in 2030

Kontis et al 2017 THE LANCET 6736(16)32381-9

Posterior distribution of life expectancy and its median value. Red dots show the posterior medians.

Female life expectancy at birth in 2030: Top 10

Oldest age at which at least 50% of a birth cohort is still alive (Birth Cohorts 2000-2007)

104

101

104

102

104

107

103

104

96

98

100

102

104

106

108

2000 2001 2002 2003 2004 2005 2006 2007

Canada

DenmarkFrance

GermanyItaly

Japan

UK

Source: Human Mortality Data Base, Christiansen et al Lancet 2009

Centenarians

Centenarians

Leeson, G. (2014) Future prospects for longevity. Post Reproductive Health, 20 (1), 17-21

Source: Oxford Institute of Population Ageing Human Mortality Data Base

2010 2020 2030 2040 2050 2060 2070 2080

CentenariansProjected number of centenarians in the USA

6m

5m

4m

3m

2m

1m

>1m

Will increases in life expectancy be accompanied by increases in life extension or are we seeing a compression of longevity after 100?

– will the predicted increases in centenarians over the coming century be accompanied by increases in super-centenarians?

111 year old Great,great,great,grandmother

0

1000

2000

3000

4000

5000

0 10 20 30 40 50 60 70 80 90 100 110 120

Age

d(x

) fu

ncti

on

, li

fe t

ab

le

1950-1954

1960-1964

1970-1974

1980-1984

1990-1994

2000-2004

Change in the distribution of ages at death for women in Japan from 1950-54 to 2000-2004

Cheung and Robine, 2007

0

1000

2000

3000

4000

5000

0 10 20 30 40 50 60 70 80 90 100 110 120

Age

d(x

) fu

ncti

on

, li

fe t

ab

le

1950-1954

1960-1964

1970-1974

1980-1984

1990-1994

2000-2004

0

1000

2000

3000

4000

5000

0 10 20 30 40 50 60 70 80 90 100 110 120

Age

d(x

) fu

ncti

on

, li

fe t

ab

le

1950-1954

1960-1964

1970-1974

1980-1984

1990-1994

2000-2004

Change in the distribution of ages at death for women in Japan from 1950-54 to 2000-2004

Cheung and Robine, 2007

In our genes? Do some of us simply age less fast than others…..?

“….longevity case participants were healthier than controls despite the fact they were on average 10.8 years older. They possessed significantly better biological and physiological risk factor profiles, less age-related disease, and better physical and cognitive function”

Concluding with

“the concept of a “healthy aging” phenotype, whereby certain individuals are somehow able to delay or avoid major clinical disease and disability until late in life”

Robine et al 2003 The emergence of extremely old people: the case of Japan

Experimental Gerontology 38 735–739

In our Genes?

In our Genes?

“Supercentenarians displayed an exceptionally healthy aging phenotype where clinically apparent major chronic diseases and disabilities were markedly delayed, often beyond age 100. They had little clinical history of cardiovascular disease and reported no history of cancer or diabetes”.

Wilcox et al 2008 J Gerontol A Biol Sci Med Sci (2008) 63 (11): 1201-1208

“Our long-lived cases also had metabolic profiles that suggested higher insulin sensitivity at younger ages, namely lower waist:hip ratio, lower glucose levels, lower insulin.”Morris et al 2015 J Gerontol A Biol Sci Med Sci (2015) 70 (2): 133-142

Nature Debate on Longevity

X. Dong, B. Milholland & J. Vijg Nature 538, 257–259 (2016)

“Our results strongly suggest that the maximum lifespan of humans is fixed (115) and subject to natural constraints”

“….what appears to be a ‘natural limit’ is an inadvertent by-product of fixed genetic programs for early life events such as development, growth and reproduction. Limits to the duration of life could well be determined by a set of species- specific, longevity-assurance systems encoded in the genome that counteract these inadvertent by-products, which are likely to include inherent

Imperfections in transferring genetic information into cellular function”.

REPOST“Current understanding of the biology of ageing points firmly away from any idea that the end of life is itself genetically programmed….”

Will life expectancy increase

in line with life extension?

- will we all enjoy the benefits of

longevity or will it be for a few?

Source: Sample copy Viacheslav Iakobchuk

Life expectancy at birth in EU-28 slightly declined in 2015

Declining US Life Expectancy: Harper, S. Kaufman, J. Cooper, Richard S

Epidemiology: November 2017 - Volume 28 -Issue 6 - p e54–e56

Have mortality improvements stalled

in England?

Editorial BMJ May 2017:357

Inequality in Mortality

Harper, S. Howse, K. Baxter, S.UK data set: 2.5 millionOccupational Pension Records

Differential longevity

Source: Oxford Institute of Population Ageing

Proportion of 65 year old men expected to survive to each older age

Source: Oxford Institute of Population Ageing

100

75

50

25

0

65 75 85 95Age

% probability of reaching age x

Unhealthy lifestyle, ill health retiree, poor

Healthy lifestyle, normal health retiree, rich

‘Average’ individual

Impact of different factors on longevity

Remaining LE from 65

Life Expectancy and Healthy Life Expectancy

Title of presentationSource: Future of an Ageing Population, Foresight, 2016

RISKS

1. Will increases in life expectancy continue?

2. Will advances in life expectancy be matched by advances in healthy life expectancy?

Life expectancy (LE) and healthy life years (HLY), selected countries, women at age 60

Source: WHO

15

17

19

21

23

25

27

29

31

2000 2005 2010 2015

Re

mai

nin

g ye

ars

of

life

Spain LE

France LE

Japan LE

UK LE

USA LE

Spain HLE

France HLE

Japan HLE

UK HLE

USA HLE

Life expectancy (LE) and healthy life years (HLY), selected EU countries, women, age 80

1

2

3

4

5

6

7

8

9

2006 2007 2008 2009 2010 2011 2012 2013 2014 2015

Re

mai

nin

g ye

ars

of

life

France LE

Spain LE

UK LE

France HLY

Spain HLY

UK HLY

Source: http://www.eurohex.eu/

A Potential Decline in Life Expectancy in the United States in the 21st Century, Olshansky S J et al 2005 N Engl J Med 2005; 352:1138-1145

“There are other realistic threats to increases in life expectancy…. death from infectious diseases …..fuelled mostly by the AIDS epidemic ….”

“We anticipate that as a result of the substantial rise in the prevalence of obesity and its life-shortening complications such as diabetes, life expectancy at birth and at older ages could level off or even decline within the first half of this century”.

Higher BMI is associated with risk factors for vascular disease

BMI 15-50kg/m2

Excluding first 5 years of follow-up

Lopez-Jimenez F. The Lancet. 2009.

0

10

20

30

40

50

60

70

80

90

100A

ge-a

dju

sted

rel

ativ

e ri

sk o

f d

iab

etes

BMI category (kg/m2)Colditz et al. (1995) Ann Intern Med 122(7): 481-6

Higher BMI is associated with an increased risk of diabetes

Higher BMI is associated with reduced life expectancy

Lopez-Jimenez F. The Lancet. 2009.

Oxford Institute of Population Ageing

Increase in

Disabled Years

Age 55 Reduced

LE

Increased

DY

Obesity 1.4 5.9

Smoking 4 3.8

Alcohol 3 3.1Klijs et al., 2011Obesity, smoking, alcohol consumption

and years lived with disability, BMC Public Health 11:378

RISKS

1. Will increases in life expectancy continue?

2. Will advances in life expectancy be matched by advances in healthy life expectancy?

3. Even with advances in healthy life expectancy, will increases in the numbers of older adults increase morbidity within the population?

Two decade comparison of incidence rates for dementia in 65+ population –big improvement in ‘brain health’

Cognitive Function and Ageing Study – Nature Communications 2016 – FE Matthews et al.

Estimated 183,000 cases in UK in 1991. Using 1991 IRs, projected estimate for 2015 would be 251,000 i.e. 37% increase as a result of population change (growth + ageing)

Based on 2011 IRs, estimated 210,000 cases in UK in 2015, i.e. much smaller than CFAS I projection. Age-standardised incidence in 65+ fell by 20% over two decades. But still a 15% increase in absolute numbers (new cases per year)

Dementia prevalence declined significantly, from 11.6%in 2000 to 8.8% in 2012. Influence of one years extra schooling.

21,000 US adults 65 years or older from the nationally representative Health and Retirement Study.

Cognitive reserve hypothesis— clinical manifestation of dementia is delayed in people with higher education, a steeper decline occurs at a certain threshold.

Langa et al, 2016 A Comparison of the Prevalence of Dementia in the United States in 2000 and 2012 JAMA Intern Med..2016.6807

Estimated numbers of people with dementia by age: big increase in numbers even if incidence continues to decline

I

Assumes 2.7% annual decline in incidence

Ahmadi-Abhari et al 2017

25% increase in numbers of older people with disability (unable to carry out 1 or more ADL) if age-specific risk of serious disability declines

Model (IMPACT-BAM) assumes continuing reductions in incidence of dementia and CVD as well as continuing mortality reductions.

Guzman-Castillo et al 2017

Crude incidence of heart failure would be reduced by 18% if whole population had incidence of least deprived quintile

Conrad et al Lancet 2018

Determinants of the shape of mortality and morbidity in 21st Century

• Healthy Living

• Disease Prevention and Cure

• Regenerative medicine

• Age-Retardation.

Key Question

How much life expectancy can we expect to gain without the intensive application of scientific medicine?

Estimate the impact on life expectancy of delaying the onset of what we know to be age-related diseases rather than eliminating them altogether.

16%

18%

13%

4%

15%

28%

33%

28%

13%

31%

0%

5%

10%

15%

20%

25%

30%

35%

Heart disease Stroke Cardiovasular disease Cancer Premature death

Percentage reduced risk in developing illness

2 and a half portions 10 portions

Source: International Journal of Epidemiology

Determinants of the shape of mortality and morbidity in 21st Century

• Healthy Living

• Disease Prevention and Cure

• Regenerative medicine

• Age-Retardation.

Key Question

How much life expectancy can we expect to gain with the intensive application of scientific medicine?

Bio-Technology

Pushing back death into later and later ages

Projected increase in deaths for England & Wales 2014-2040. Bone et al 2017

https://www.gov.uk/government/.../future-of-an-ageing-population

https://www.gov.uk › Industrial Strategy: the Grand Challenges

https://www.gov.uk/government/publications/harnessing-technology-to-meet-increasing-case-needs

https://www.ageing.ox.ac.uk/news/industrial-challenge-healthy-ageing